Find link

language:

Find link is a tool written by Edward Betts.

searching for Cytokinetics 8 found (17 total)

Astellas Pharma (2,449 words) [view diff] exact match in snippet view article find links to article

December 2014, Astellas expanded its 18-month-old collaboration with Cytokinetics, focusing on the R&D and commercialization of skeletal muscle activators

Aficamten (333 words) [view diff] exact match in snippet view article find links to article

Aficamten (CK-274) is a cardiac myosin inhibitor developed by Cytokinetics for the treatment of obstructive hypertrophic cardiomyopathy. Chuang, Chihyuan;

Omecamtiv mecarbil (1,535 words) [view diff] exact match in snippet view article find links to article

S2CID 9411257. Mast J (9 October 2020). "R&D Amgen's big cardiovascular bet with Cytokinetics hits PhIII primary but dramatically disappoints investors". Endpoints

CBL Properties (872 words) [view diff] exact match in snippet view article find links to article

Business Wire. January 30, 2017. "Gigamon, CBL & Associates Properties and Cytokinetics Set to Join S&P SmallCap 600" (Press release). PR Newswire. April 17

Lawrence S.B. Goldstein (451 words) [view diff] exact match in snippet view article find links to article

research. As a cofounder and consultant of the biotechnology company Cytokinetics, Inc. he has also had an active role in private industry. Goldstein has

Kinesin-like protein KIF11 (7,112 words) [view diff] exact match in snippet view article find links to article

promising preclinical studies, ispinesib (SB-715992; Cytokinetics/GSK), SB-743921 from Cytokinetics/GSK, MK-0731 from Merck, filanesib (ARRY-520) (Array

Foresite Capital (825 words) [view diff] exact match in snippet view article find links to article

Pharmaceuticals, Ascendis, Blueprint Medicines, Color Genomics, Cue Health, Cytokinetics, DNAnexus,[citation needed] Editas Medicine, Eikon Therapeutics, Epizyme

Spinal muscular atrophy (9,941 words) [view diff] exact match in snippet view article find links to article

Reldesemtiv (CK-2127107, CK-107) is a skeletal troponin activator developed by Cytokinetics in cooperation with Astellas. The drug aims at increasing muscle reactivity